The Cooper Companies, Inc

Price Chart

Risk-Adjusted Performance

Also Listed On

The Cooper Companies, Inc (COO) Price Performance

The Cooper Companies, Inc (COO) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at $69.96, down 1.70% from the previous close.

Over the past year, COO has traded between a low of $64.32 and a high of $84.98. The stock has lost 16.4% over this period. It is currently 17.7% below its 52-week high.

The Cooper Companies, Inc has a market capitalization of $13.64B, with a price-to-earnings ratio of 34.79.

About The Cooper Companies, Inc

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.